Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results

>-1,930,000Equity:Shareholders' equity:Common stock - no par value; 100,000,000 shares authorized;20,358,586 and 20,180,486(1) shares issued and outstandingas of June 30, 2010 and December 31, 2009, respectively

68,199,16567,711,746Retained earnings

5,153,0084,542,126Total shareholders' equity

73,352,17372,253,872Noncontrolling interests

(50,143)(32,536)Total equity

73,302,03072,221,336Total liabilities and equity

$ 96,702,030$  103,724,320(1) Number of shares issued and outstanding represent total shares of common stock regardless of classification on the consolidated balance sheet. The number of shares of redeemable common stock at December 31, 2009 was 142,016.CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Statements of Income(Unaudited)Three months ended June 30,Six months ended June 30,2010200920102009Net revenues

$  10,739,935$ 9,820,613$  20,870,587$  19,225,212Costs and expenses:Cost of products sold

863,725777,0761,723,0131,510,294Selling and marketing

5,848,1234,383,80211,455,6358,523,989Research and development

1,034,8002,630,7251,808,6683,400,842General and administrative

1,782,8341,236,4353,664,0372,681,298Amortization of product license right


28,86726,73355,41454,196Total costs and expenses

9,730,0759,226,49719,050,21916,514,071Operating income

1,009,860594,1161,820,3682,711,141Interest income

50,33410,160111,01327,756Interest expense

(405,956)(84,224)(751,908)(181,935)Net income before income taxes

654,238520,0521,179,4732,556,962Income tax expense

(374,461)(232,637)(586,198)(1,063,696)Net income

279,777287,415593,2751,493,266Net loss at subsidiary attributable tononcontrolling interests

7,5278,45617,60720,695Net income attributable tocommon shareholders

,513,961Earnings per share attri

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
2. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
3. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
4. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
5. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
6. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
7. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
8. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
9. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
Post Your Comments:
(Date:10/9/2015)... CITY, Calif. , Oct. 9, 2015 AcelRx ... presentation will be made at the annual European Society of ... to October 14 th , 2015 at the Lingotto ... annual EuSEM is the largest meeting of emergency medicine practitioners ... 90 countries represented. Data from the previously announced ...
(Date:10/9/2015)... LAUSANNE , Suiza, October 9, 2015 El ... Yutaka Kondo y Junko Takita ... se ha otorgado a los doctores Yutaka Kondo ... El ,JCA-Mauvernay Award 2015, se ha otorgado a los ... Junko Takita    ™ , una compañía biofarmacéutica global con ...
(Date:10/8/2015)... Oct. 8, 2015  Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that clinical ... will be presented at the 2015 American College ... include measures of sustained response in IBS-C patients ... randomized Phase 2 trial. The meeting will be ...
Breaking Medicine Technology:
... 29 Watson Pharmaceuticals, Inc. (NYSE: WPI ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the 2010 Credit Suisse Healthcare Conference on Thursday, ... The presentation will be webcast live and can be ...
... Oct. 29 See video from Roche ... Roche announced on October ... the use of MabThera (rituximab) as a ... lymphoma who have responded to initial induction ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... Prescription Hope, ... all walks of life to save money on the high cost of their ... month per medication, individuals and families can receive their medications delivered direct from ...
(Date:10/9/2015)... ... October 09, 2015 , ... ViewPoint Center, a teen mental ... teenagers facing mental illness, the stigma associated with mental illness causes many to hide ... understands the importance of supporting teens with mental illness , providing teens with ...
(Date:10/9/2015)... ... 09, 2015 , ... Ryan Fox, the founder and CEO ... Colorado, says the latest figures on the state’s sales of legalized marijuana acknowledge ... industry. , Last month, according to the website , Colorado's ...
(Date:10/9/2015)... ... 09, 2015 , ... Amada Senior Care, premier provider of ... in Maryland – its Bethesda location. Amada franchise partner Steve Schultz ... technology consultant to many of the largest construction firms in the Mid-Atlantic region. ...
(Date:10/9/2015)... , ... October 09, 2015 , ... Smanos was featured ... coolest technology products available to consumers. Scott Steinberg, a technology expert and special reporter ... perfect for any home or dorm. , In this day and age it’s more ...
Breaking Medicine News(10 mins):
... it for 6 months, study finds , , TUESDAY, March 10 ... many overweight/obese blacks lose 5 percent or more of their ... for at least six months. , The study included 35 ... mass index (BMI) of 36. They took part in a ...
... Insight in IndustrySACRAMENTO, Calif., March 10 Donna ... of experience, has joined Alliance Seating & ... growing accredited complex rehab companies. Cole is an ... Calif., for ASM ( ) and provides ...
... Glancy Brings Variety of Experience with Complex Rehab MarketDETROIT, ... with more than 12 years of experience, has joined ... the nation,s fastest growing accredited complex rehab companies. Glancy ... Detroit, Mich., for ASM ( ) and provides ...
... and regulation for the European Union, has approved a ... type of bone cancer. The approval is based on ... Texas M. D. Anderson Cancer Center and a national ... immune-based therapy, that when combined with chemotherapy, resulted in ...
... March 10 CPC of America, Inc. (OTC ... development of therapeutic devices that enhance the quality ... that it is actively pursuing the development of ... of its global commercialization strategy for MedClose(TM). ...
... after reports find a connection, , , TUESDAY, March 10 (HealthDay ... heart disease -- can work together to speed dementia and ... One expert thinks these papers, published in the March issue ... people can take steps to reduce their risk of developing ...
Cached Medicine News:
B-Hemoglobin test system provide quick, simple and reliable quantitative hemoglobin results. It has unbreakable, disposable cuvette which collect the exact amount of blood and mixes the sample with t...
... The Variant hemoglobin ... fast, accurate testing for ... screening, beta-thalassemia testing, hemoglobinopathy ... from a single test. ...
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
... LH 755 simplifies and automates ... expert automation and advanced technologies ... reliable, accurate results every time. ... slide quality with its slide-on-slide ...
Medicine Products: